Philly biotech earns FDA approval for first-of-its-kind cancer therapy - The Philadelphia Inquirer

Retrieved on: 2024-08-02 20:36:10

Tags for this article:

Sarcoma

Cancer immunotherapy

T cell receptor T cell therapy

u.s. food and drug administration

Click the tags to see associated articles and topics

Philly biotech earns FDA approval for first-of-its-kind cancer therapy - The Philadelphia Inquirer. View article details on hiswai:

Excerpt

Tecelra is one of many ways researchers are exploring how to train the body's immune system to fight cancer. Along with Tecelra, the FDA has given ...

Article found on: www.inquirer.com

View Original Article